ReviewJournal of clinical medicine2025

Efficacy and Safety of Combination Therapy with PARP Inhibitors and Anti-Angiogenic Agents in Ovarian Cancer: A Systematic Review and Meta-Analysis.

István Baradács et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.